Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | PALB2 |
| Variant | L961P |
| Impact List | missense |
| Protein Effect | loss of function |
| Gene Variant Descriptions | PALB2 L961P lies within WD repeat 2 of the Palb2 protein (UniProt.org). L961P confers a loss of function to the Palb2 protein as demonstrated by decreased protein stability, reduced Rad51 foci formation, and impaired homology-directed DNA repair activity compared to wild-type in cultured cells (PMID: 31757951). |
| Associated Drug Resistance | |
| Category Variants Paths |
PALB2 mutant PALB2 inact mut PALB2 L961P |
| Transcript | NM_024675.4 |
| gDNA | chr16:g.23623083A>G |
| cDNA | c.2882T>C |
| Protein | p.L961P |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| XM_017023672 | chr16:g.23623083A>G | c.2882T>C | p.L961P | RefSeq | GRCh38/hg38 |
| XM_017023673.2 | chr16:g.23623083A>G | c.2882T>C | p.L961P | RefSeq | GRCh38/hg38 |
| NM_024675.4 | chr16:g.23623083A>G | c.2882T>C | p.L961P | RefSeq | GRCh38/hg38 |
| NM_024675.3 | chr16:g.23623083A>G | c.2882T>C | p.L961P | RefSeq | GRCh38/hg38 |
| NM_001407301.1 | chr16:g.23623083A>G | c.2882T>C | p.L961P | RefSeq | GRCh38/hg38 |
| XM_017023673 | chr16:g.23623083A>G | c.2882T>C | p.L961P | RefSeq | GRCh38/hg38 |
| NM_001407299.1 | chr16:g.23623083A>G | c.2882T>C | p.L961P | RefSeq | GRCh38/hg38 |
| NM_024675 | chr16:g.23623083A>G | c.2882T>C | p.L961P | RefSeq | GRCh38/hg38 |
| XM_017023672.2 | chr16:g.23623083A>G | c.2882T>C | p.L961P | RefSeq | GRCh38/hg38 |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|---|---|---|---|---|---|---|
| PALB2 L961P | Advanced Solid Tumor | sensitive | Olaparib | Preclinical - Cell culture | Actionable | In a preclinical study, Lynparza (olaparib) treatment decreased viability of cells expressing PALB2 L961P in culture (PMID: 31757951). | 31757951 |
| PALB2 L961P | Advanced Solid Tumor | sensitive | Cisplatin | Preclinical - Cell culture | Actionable | In a preclinical study, Platinol (cisplatin) treatment decreased viability of cells expressing PALB2 L961P in culture (PMID: 31757951). | 31757951 |